Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on asymmetric catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN101675020A details a novel asymmetric hydrogenation method for high-purity optically active aldehydes like citronellal, offering enhanced catalyst stability and supply chain reliability.
High-purity chiral ligands and metal complexes for asymmetric synthesis. Efficient routes for pharmaceutical intermediates with superior enantioselectivity.
Patent CN1761642A details an efficient asymmetric hydrogenation process for chiral beta-amino acids, offering significant cost reduction and supply chain reliability for API manufacturing.
Advanced asymmetric oxidation process for high-purity Esomeprazole Sodium. Reduces impurities and enhances supply chain stability for global pharmaceutical manufacturers.
Novel non-silylated route for Ezetimibe intermediates reduces cost and complexity. Ideal for reliable API intermediate supplier partnerships.
Patent CN103467313A discloses a novel chiral copper complex enabling efficient Henry reactions, offering cost reduction in fine chemical manufacturing and reliable supply chain solutions.
Patent CN103570768A reveals a novel chiral cobalt-nitrogen complex enabling efficient Henry reactions, offering cost reduction in fine chemical manufacturing and reliable supply chain solutions.
Patent CN103833560B reveals a safer Zn-catalyzed route for Efavirenz intermediates. Discover cost-effective, scalable manufacturing solutions for global supply chains.
Patent CN100584459C reveals a novel metal-free organocatalyst enabling dual-handed synthesis of gamma-nitro ketones with >99% ee, offering significant cost reduction and supply chain reliability.
Patent CN111269132B reveals a biomimetic pyridoxal catalytic route for high-purity chiral amino acids, offering significant cost reduction and scalable manufacturing for pharmaceutical intermediates.
Patent CN109942514B details a cost-effective L-phenylalanine route for Atazanavir intermediates, offering high purity and scalable manufacturing solutions.
Patent CN111548298B details a novel organocatalytic route for chiral trifluoromethyl maleimides, offering high stereoselectivity and simplified supply chains for pharmaceutical intermediates.
Advanced patent CN106146543A enables efficient synthesis of chiral alpha-amino tertiary borates. High enantioselectivity and scalable process for pharmaceutical intermediates.
Novel ferrocene-derived iridium catalyst enables high-efficiency chiral amine synthesis with reduced processing costs for reliable agrochemical intermediate supply chains.
Novel chiral Lewis acid process for high-purity diltiazem intermediates. Reduces steps and eliminates expensive reagents for scalable pharmaceutical manufacturing.
Patent CN1530171A discloses a robust heterogeneous catalyst system for producing high-ee hydroxy esters, enabling significant cost reduction in chiral synthesis manufacturing.
Patent CN85103245A details novel rhodium-diphosphine complexes enabling high-yield asymmetric hydrogenation for pharmaceutical intermediates with reduced catalyst loading.
Patent CN1626501A details a high-efficiency ruthenium-catalyzed asymmetric Michael addition for producing optically active nitro and cyano compounds, offering significant cost reduction in API manufacturing.
Patent CN101039894A reveals stabilized Rh-catalyzed asymmetric hydrogenation for high-purity citronellal production, offering significant cost reduction in flavor manufacturing.
Novel intermediates and methods for CPT-11 and mappicine synthesis offering improved yield and chiral control for pharmaceutical manufacturing supply chains.